Neurological manifestations of Epstein-Barr virus and cytomegalovirus infection
Vol. 37 No. 1 Supl 1 (2021), Original Research Articles
Vol. 37 No. 1 Supl 1 (2021)

Neurological manifestations of Epstein-Barr virus and cytomegalovirus infection

Original Research Articles
https://doi.org/10.22379/24224022319
Published 2021-05-20
Stephanie Pinzón Cadena
Médica general, Universidad Nuestra Señora del Rosario, Bogotá, Colombia.
Hellen Kreinter Rosenbaun
Residente de Neurología Clínica, Universidad El Bosque, Bogotá, Colombia; Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Habib Georges Moutran Barroso
Residente de Neurología Clínica, Universidad El Bosque, Bogotá, Colombia; Fundación Santa Fe de Bogotá, Bogotá, Colombia.
María Isabel Medina de Bedout
Neuróloga clínica, Hospital Simón Bolívar, Bogotá, Colombia; profesora adscrita a la Universidad El Bosque, Bogotá, Colombia.
PDF (Español)
XML (Español)

Keywords

herpesvirus
cytomegalovirus
Epstein-Barr
central nervous system
peripheral nervous systems (MeSH)

Abstract

The herpesvirus family is a large family composed of several members including Herpes simplex type 1 and 2, Varicella Zoster, Cytomegalovirus, Epstein barr and Herpesvirus 6, which in recent years have been shown to infect the entire neuraxis, therefore It is vitally important to recognize the initial symptoms and perform appropriate tests to identify and effectively manage these infections to avoid neurological sequelae devastating and disabling for patients. In this section the Epstein virus will be reviewed by Barr where he will address the pathophysiology, diagnosis and treatment.

https://doi.org/10.22379/24224022319

PDF (Español)
XML (Español)

References

Tselis, AC. Chapter 13: Epstein-Barr virus infections of the nervous system. En: Handbook of clinical neurology. Vol. 123; 2014. p. 285-305.

Tsuruyama Y, Mori N, Yoshida S, Hayashi T. Epstein-Barr virus-related encephalitis in a young woman: A case report. J Infect Chemother. 2020;26(7):741-74. doi: 10.1016/j.jiac.2020.02.005.

Millichap JG. Epstein-Barr virus neurologic complications. Pediatr Neurol Briefs. 2015;29(11):88. doi: 10.15844/pedneurbriefs-29-11-7.

Baldwin KJ, Cummings CL. Herpesvirus infections of the nervous system. Continuum (Minneap Minn). 2018;24(5, Neuroinfectious Disease):1349-69. doi: 10.1212/CON.0000000000000661.

Avindra N, Berger, JR. Clinical neurovirology. Segunda edición. Taylor and Francis; 2018.

Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas y Bennett: Compendio de enfermedades infecciosas. Barcelona: Elsevier; 2017.

Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, et al. Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI Insight. 2020;5(20):e144624. doi: 10.1172/jci.insight.144624. Erratum for: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Tselis A, Duman R, Storch GA, Lisak RP. Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology. 1997;48(5):1351-5. doi: 10.1212/wnl.48.5.1351.

Majid A, Gaietta SL, Sweeney CJ, Robinson C, Mahalingam R, Smith J, Forghani B, Gilden DH. Epstein-Barr virus myelo-radiculitis and encephalomyeloradiculitis. Brain. 2002;125(Pt 1):159-65. doi: 10.1093/brain/awf010.

Martelius T, Lappalainen M, Palomàki M, Anttila VJ. Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid. BMC Infect Dis. 2011;11:281. doi: 10.1186/14712334-11-281.

Mazur-Melewska K, Breñska I, Joñczyk-Potoczna K, Kemnitz P, Pieczonka-Ruszkowska I, Mania A, Sluzewski W, Figlerowicz M. Neurologic complications caused by Epstein-Barr virus in pediatric patients. J Child Neurol. 2016;31(6):700-8. doi: 10.1177/0883073815613563.

Bathoorn E, Vlaminckx BJ, Schoondermark-Stolk S, Donders R, van der Meulen M, Thijsen SF. Primary Epstein-Barr virus infection with neurological complications. Scand J Infect Dis. 2011;43(2):136-44. doi: 10.3109/00365548.2010.531760.

Brazis PW, Stewart M, Lee AG. The uveo-meningeal syndromes. Neurologist. 2004;10(4):171-84. doi: 10.1097/01.nrl.0000131145.26326.ff.

Ray R, Foroozan R. Uveo-meningeal syndromes. Int Ophthalmol Clin. 2007;47(4):131-49. doi: 10.1097/IIO.0b013e3181572281.

Maschke M, Kastrup O, Diener HC. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs. 2002;16(5):303-15. doi: 10.2165/00023210200216050-00003.

Reñé R, Salazar A, Ferrer X. Complicaciones neurológicas por citomegalovirus en pacientes con SIDA. Rev Neurol. 1996;24(136): 1590-6.

Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ. 1973;49(1):103-6.

Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S, Tsutsui Y. Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab Invest. 2000;80(9):1373-83. doi: 10.1038/labinvest.3780145.

Tselis AC. Chapter 14: Cytomegalovirus infections of the adult human nervous system. En: Handbook of clinical neurology; 2014. p. 307-18.

Maple PAC. Cytomegalovirus and Epstein-Barr virus associations with neurological diseases and the need for vaccine development. Vaccines (Basel). 2020;8(1):35. doi: 10.3390/vaccines8010035.

Rodríguez Y, Rojas M, Pacheco Y, Acosta-Ampudia Y Ramírez-Santana C, Monsalve DM, Gershwin ME, Anaya JM. Guillain-Barré syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018;15(6):547-62. doi: 10.1038/cmi.2017.142.

Lanciai D, Faddy HM, Flower R, Hogan C. Cytomegalovirus disease in immunocompetent adults. Med J Aust. 2014;201(10):578-80. doi: 10.5694/mja14.00183.

Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review Virol J. 2008;5:47. doi: 10.1186/1743-422X-5-47.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.